Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer
Jean Hoffman-Censits (@JCensits) / X
Jean HOFFMAN-CENSITS | Thomas Jefferson University, Philadelphia | Jefferson | Department of Medical Oncology | Research profile
A Novel Study for Patients with Small Cell Bladder Cancer - Johns Hopkins Medicine
Jefferson Health - On the blog: With Bladder Cancer Awareness Month coming up in May, we spoke with Dr. Jean Hoffman-Censits, M.D. Director of the Genitourinary Multidisciplinary Cancer Clinic Department of Medical
Jefferson Health - Meet our Staff: Jean Hoffman-Censits, M.D. Dr. Hoffman- Censits is an Assistant Professor at Thomas Jefferson University and Director of the Genitourinary Multidisciplinary Cancer Clinic Department of Medical Oncology, Division
Sidney Kimmel Cancer Center's Dr. Hoffman-Censits on Good Day Philadelphia Weekend - YouTube
Jean Hoffman-Censits (@JCensits) / X
Dr. Hoffman-Censits on Biomarker Development in Urothelial Carcinoma - YouTube
Dr. Jean Hoffman-Censits on the Results of a Phase II Trial Studying Atezolizumab in Bladder Cancer - YouTube
Jean Hoffman-Censits, MD - Johns Hopkins Medicine
Zeroing In On an Overlooked Cancer | Giving to Johns Hopkins
Jean Hoffman-Censits (@JCensits) / X
80+ "Jean Hoffman" profiles | LinkedIn
Jean Hoffman-Censits (@JCensits) / X
AUA Guidelines for Upper Tract Urothelial Carcinoma: Streamlined Approaches and Novel Opportunities for Treatment - Jean Heather Hoffman-Censits
Jean Hoffman-Censits - Co-Director, Women's Bladder Cancer Program - Sidney Kimmel Cancer Center at Johns Hopkins | LinkedIn
Jean Hoffman-Censits (@JCensits) / X
ESMO Virtual Congress 2020: Real-World Evidence of the Impact of Prior Autoimmune Disease on Immune Checkpoint Inhibitor Outcomes in Patients with Metastatic Urothelial Cancer
1245480607 NPI Number | JEAN H. HOFFMAN-CENSITS MD | BALTIMORE, MD | NPI Registry | Medical Coding Library | www.HIPAASpace.com © 2023
Jean Hoffman-Censits (@JCensits) / X
Atezolizumab generates excitement in advanced urothelial cancer | MDedge Hematology and Oncology
Jean Hoffman-Censits | Cancer Matters
Jean Hoffman-Censits - Co-Director, Women's Bladder Cancer Program - Sidney Kimmel Cancer Center at Johns Hopkins | LinkedIn
